Short- and intermediate-term results of 32P radioactive β-emitting stent implantation in patients with coronary artery disease: The Milan dose- response study

Circulation

Volumn 101, Issue 1, 2000, Pages 18-26

  Albiero, Remo ^a   Adamian, Milena ^a   Kobayashi, Nobuyuky ^a   Amato, Antonio ^a   Vaghetti, Marco ^a   Di Mario, Carlo ^a   Colombo, Antonio ^a  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

Coronary disease; Radioisotopes; Restenosis; Stents

Indexed keywords

PHOSPHORUS 32;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; BETA RADIATION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RESTENOSIS;

EID: 0034602820     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.1.18     Document Type: Article

References (35)

1. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation. 1991;84:1426-1436.
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
3. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angio-plasty in patients with coronary artery disease. N Engl J Med. 1994;331: 489-495.
4. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanism of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94: 1247-1254.
5. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intra-coronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol. 1994;23:1491-1498.
6. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: a possible role for radiation therapy in restenosis prevention. Circulation. 1995;91:1533-1539.
7. Weinberger J, Amols H, Ennis RD, Schwartz A, Wiedermann JG, Marboe C. Intracoronary irradiation: dose response for the prevention of restenosis in swine. Int J Radiat Oncol Biol Phys. 1996;36:767-775.
8. Mazur W. Ali MN, Khan MM, Dabaghi SF, DeFelice CA, Paradis PJ, Butler EB, Wright AE, Fajardo LF, French BA, Raizner AE. High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses, Int J Radiat Oncol Biol Phys. 1996;36:777-788.
9. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997;336:1697-1703.
10. King SB III, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R, Macdonald J, Anderberg K, Crocker IR. Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty: results of the Beta Energy Restenosis Trial (BERT). Circulation. 1998;97:2025-2030.
11. Hehrlein C, Stintz M, Kinscherf R, Schlosser K, Huttel E, Friedrich L, Fehsenfeld P, Kubler W. Pure β-particle-emitting stents inhibit neointima formation in rabbits. Circulation. 1996;93:641-645.
12. Carter AJ, Laird JR, Bailey LR, Hoopes TG, Farb A, Fisehell DR, Fischell RE, Fisehell TA, Virmani R. Effects of endovascular radiation from a β-particle-emitting stem in a porcine coronary restenosis model: a dose-response study. Circulation. 1996;94:2364-2368.
13. Fischell TA, Carter A, Foster M, Fischell RE, Fischell DR. Lessons from the feasibility radioactive (IRIS) stent trials. In: Waksman R, ed. Vascular Brachytherapy. 2nd ed. Armonk, NY: Futura Publishing Co; 1999: 475-481.
14. Moses J. US IRIS trials low-activity 32P stent. In: Cardiovascular Radiation Therapy III. Washington, DC: 1999:387-388. Abstract.
15. Moses JW, Ellis SG, Bailey SR, Raybuck BD, Teirstein PS, Weissman NJ, Popma JJ. Short-term (1 month) results of the dose response IRIS feasibility study of a beta-particle emitting radioisotope stent. J Am Coll Cardiol. 1998;31:350A. Abstract.
16. Lansky AJ, Popma JJ, Colombo A, Kuntz RE, Bailey S, Teirstein P, Ellis S, Leon MB, Moses J. Follow-up angiographic comparison of the low dose vs high dose phosphorus-32 radioactive isostent: results from expanded IRIS and Milan Dose A Studies. J Am Coll Cardiol. 1999; 33:17A. Abstract.
17. Carter AJ, Scott D, Rahdert D, Bailey L, De Vries J, Ayerdi K, Turnlund T, Jones R, Virmani R, Fischell TA. Stent design favourably influences the vascular response in normal porcine coronary arteries. J Invas Cardiol. 1999;11:127-134.
18. Weinberger J. Irradiation and stenting. Semin Interv Cardiol. 1997;2: 103-108.
19. Reimers B, di Mario C, Di Francesco L, Moussa I, Blengino S, Martini G, Reiber JH, Colombo A. New approach to quantitative angiographic assessment after stent implantation. Cathet Cardiovasc Diagn. 1997;40: 343-347.
20. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WLJ. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. Circulation. 1988;78:486-502.
21. Albiero R, Rau T, Schluter M, Di Mario C, Reimers B, Mathey DG, Tobis JM, Schofer J, Colombo A. Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. Circulation. 1997;96:2997-3005.
22. Tobis JM, Mallory J, Mahon D, Lehman K, Zalesky P, Griffith J, Gessert J, Moriuchi M, McRae M, Dwyer ML, Greep N, Henry WL. Intravascular ultrasound imaging of human coronary arteries in vivo: analysis of tissue characteristics with comparison to in vitro histological specimens. Circulation. 1991;83:913-926.
23. Nishimura RA, Edwards WD, Warnes CA, Reeder GS, Holmes DRJ, Tajik AJ, Yock PG. Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol. 1990;16:145-154.
24. Nakamura S, Hall P, Blengino S, Maiello L, Itoh A, Martini G, Finci L, Colombo A. Reproducibility of intravascular ultrasound measurements. Eur Heart J. 1995;16:P1193. Abstract.
25. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
26. Hehrlein C, Brachmann J, Hardt S, Hansen A, Kubler W, Bode C. P-32 stents for prevention of restenosis: results of the Heidelberg safety trial using the Palmaz-Schatz stent design at moderate activity levels in patients with restenosis after PTCA. Circulation. 1998;98(suppl 1):I-780. Abstract.
27. Wardeh AJ, Gijzel AL, van der Giessen WJ, Ligthart JMR, Coen VLMA, Sabaté MS, Levendag PC, den Boer A, Serruys PW. β-Particle emitting radioactive stent to prevent restenosis. J Am Coll Cardiol. 1999;33:21A. Abstract.
28. Hehrlein C. Radioactive stents: the European experience. In: Waksman R, ed. Vascular Brachytherapy. 2nd ed. Armonk, NY: Futura Publishing Co; 1999:333-342.
29. Fischell TA, Carter AJ, Laird JR. The beta-particle-emitting radioisotope stent (Isostent): animal studies and planned clinical trials. Am J Cardiol. 1996;78:45-50.
30. Janicki C, Duggan DM, Coffey CW, Fischell DR, Fischell TA. Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent. Med Phys. 1997;24:437-445.
31. Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Wong SC, Leon MB. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol. 1995;26:720-724.
32. Ikari Y, Hara K, Tamura T, Saeki F, Yamaguchi T. Luminal loss and site of restenosis after Palmaz-Schatz coronary stent implantation. Am J Cardiol. 1995;76:117-120.
33. Hoffmann R, Mintz GS, Kent KM, Satler LF, Pichard AD, Popma JJ, Leon MB. Serial intravascular ultrasound predictors of restenosis at the margins of Palmaz-Schatz stents. Am J Cardiol. 1997;79:951-953.
34. Carter AJ, Jenkins JS, Bailey LR, Jones R, Sweet W, Fischell TA, Virmani R. Dose rate and cumulative dose effects of P-32 radioactive stents. J Am Coll Cardiol. 1999;33:20A. Abstract.
35. 32P stents promote development of atherosclerosis at six months in a porcine model. Circulation. 1997:96(suppl I):I-607. Abstract.